A Dose Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of ASP2408 Following Single Intravenous Doses in Healthy Subjects
Clinical trial NCT02125435 · COMPLETED
Trial details
- NCT number
- NCT02125435
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2012-05-01
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.